DTaP immunization is a vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough).
See also: Tdap vaccine
InformationThe DTaP vaccine is highly effective for the prevention of diphtheria, tetanus, and pertussis -- all of which are serious, and potentially deadly, diseases. It is given by a shot (injection), usually into the arm or thigh. The DTaP vaccine may be given as part of a combination vaccine, such as Pentacel (DTaP-Hib-IPV) or Pediarix (DTaP-HepB-IPV).
WHO SHOULD GET THIS VACCINE
DTaP vaccination is one of the recommended childhood immunizations. DTaP vaccine can be safely given to infants. Five DTaP vaccines are recommended. They are usually given to children at ages 2 months, 4 months, 6 months, 15-18 months, and 4-6 years. DTaP immunization is generally required before a child can start school.
After the first series of immunizations, a Tdap vaccine should be given at around age 11 or 12, and every 10 years after that. This vaccine provides further protection against tetanus, diphtheria, and pertussis, and is used as a booster.
DTaP is recommended unless there is a reason that the child should not receive the pertussis vaccine (such as an allergic reaction), in which case a vaccine against diphtheria and tetanus (DT vaccine) only should be given.
RISKS AND SIDE EFFECTS
DTaP may cause the following mild side effects, which usually only last a few days:
Acetaminophen (Tylenol) may be used to treat common, minor side effects of fussiness, soreness, and fever after the immunization. However, there is some evidence that the use of acetaminophen before the immunization may reduce the effectiveness of the vaccine. A warm, damp cloth or a heating pad may also help to reduce soreness. Frequently moving or using the arm or leg that has received the injection is recommended and often reduces the soreness.
Moderate to serious reactions are uncommon. They may include:
Severe reactions are extremely rare, but may include severe allergic reactions such as breathing difficulties and shock. Such reactions occur in less than 1 per 1,000,000 children. Long-term seizures and brain damage are so rare that the association with the vaccine is questionable.
Many parents worry that some vaccines are not safe and may harm their baby or young child. They may ask their doctor or nurse to wait, or even refuse to have the vaccine. However, it is important to also think about the risks of not having the vaccine. See: Immunizations - general overview for more information.
Usually, a child who has had a problem with the DTaP vaccine can safely receive the Td vaccine.
CONSIDERATIONS
If your child is sick with something more serious than a mild cold, DTaP may be delayed until he or she is better.
The DTaP vaccine is not recommended if the patient developed Guillain-Barre syndrome within 6 weeks of receiving a tetanus shot.
If your child has had any of the following reactions after an earlier DTaP vaccination, check with your health care provider before the child receives another one:
CALL YOUR HEALTH CARE PROVIDER IF:
Committee on Infectious Diseases. Recommended Childhood and Adolescent Immunization Schedules -- United States, 2010.
Recommended Immunization Schedule for Persons Aged 7-18 Years--United States, 2008. MMWR. October 19, 2007 / 56(41);Q1-Q4.
Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med. 2010;152:36-39.
DTaP immunization is a combination vaccine that protects against three bacterial illnesses: Diphtheria, tetanus, and pertussis (whooping cough).
See also: Tdap vaccine
InformationThe DTaP vaccine is highly effective for the prevention of diphtheria, tetanus, and pertussis -- all of which are serious diseases. Before DTaP, these diseases often led to serious medical problems and even death.
DTaP is given by a shot (injection), usually into the arm or thigh. The DTaP vaccine may be given alone or as part of another vaccine, such as Pentacel (DTaP-Hib-IPV) or Pediarix (DTaP-HepB-IPV).
WHO SHOULD GET THIS VACCINE
DTaP vaccination is one of the recommended childhood immunizations. That means, health experts believe all children should get this vaccine.
DTaP vaccine can be safely given to infants. Five DTaP vaccines are recommended. They are usually given to children at ages 2 months, 4 months, 6 months, 15-18 months, and 4-6 years. DTaP immunization is generally required before a child can start school.
DTaP is recommended unless there is a reason that the child should not receive the pertussis vaccine (such as an allergic reaction), in which case a vaccine against diphtheria and tetanus (DT vaccine) only should be given.
RISKS AND SIDE EFFECTS
DTaP may cause the following mild side effects, which usually only last a few days:
Acetaminophen (Tylenol) may be used to treat common, minor side effects of fussiness, soreness, and fever after the immunization. However, there is some evidence that the use of acetaminophen before the immunization may reduce the effectiveness of the vaccine. A warm, damp cloth or a heating pad may also help to reduce soreness. Frequently moving or using the arm or leg that has received the injection is recommended and often reduces the soreness.
Moderate to serious reactions are uncommon. They may include:
Severe reactions are extremely rare, but may include severe allergic reactions such as breathing difficulties and shock. Such reactions occur in less than 1 per 1,000,000 children. Long-term seizures and brain damage have rarely occurred, but it is hard to tell if they were caused by the vaccine or not.
Many parents worry that some vaccines are not safe and may harm their baby or young child. They may ask their doctor or nurse to wait, or even refuse to have the vaccine. However, it is important to also think about the risks of not having the vaccine. See: Immunizations - general overview for more information.
Usually, a child can safely receive the Td vaccine, even if they had a previous problem the DTaP vaccine.
CONSIDERATIONS
The DTaP vaccine may be safely given even if the child has a mild cold or ear infection. If they are having high fevers or are sicker, the vaccine may be postponed until the illness is over.
The DTaP vaccine is not recommended if the patient developed Guillain-Barre syndrome within 6 weeks of receiving a tetanus shot.
If your child has had any of the following reactions after an earlier DTaP vaccination, check with your health care provider before the child receives another one:
CALL YOUR HEALTH CARE PROVIDER IF:
Committee on Infectious Diseases. Recommended Childhood and Adolescent Immunization Schedules -- United States, 2010.
Recommended Immunization Schedule for Persons Aged 7-18 Years--United States, 2011.MMWR. February 11, 2011 / 60(5).
Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med. 2010;152:36-39.
Committee on Infectious Diseases. Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010. Pediatrics. 2010 Jan;125(1):195-6.
Reviewed ByReview Date: 02/01/2012
David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., and Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine.
DTaP IPV Vericella MMR
GSK
The DTaP vaccine is given to children in the upper leg. They should get this vaccine at 2 months old, 4 months old, 6 months old, 15 to 18 months old, and between 4 and 6 years of age.
Tetanus, Diphtheria, and Pertussis. It's a vaccine.
Is DPT the same as DTaP or DTP?
The vaccine sometimes called the tri vaccine is the DTaP vaccine. This vaccine protects children against diphtheria, tetanus and acellular pertussis, diseases which can be deadly to young children.
lackjow . . by: rumarome :)
between the age of 6 weeks to 6 months
The Tdap is a vaccine that contains tetanus, diphtheria and pertussis. The DTaP vaccine, which protects against the same illnesses, is given to infants and children. The Tdap vaccine is now recommended for certain adults.
DefinitionThe Tdap vaccine protects against diphtheria, tetanus, and pertussis (whooping cough). All of these are serious, potentially deadly illnesses caused by bacteria.See also:TetanusDiphtheriaPertussisDTaP immunizationAlternative NamesTdap immunizationInformationTdap is not the same as DTaP. They both protect against the same diseases, but are given at different times. For information on DTaP, see: DTaP immunization.WHO SHOULD GET THIS VACCINETdap is recommended as a booster to the DTaP vaccine in people ages 11 - 64. It is given by a shot (injection), usually into the arm or thigh.Tdap vaccine is recommended for children around ages 11 or 12. Adults ages 19 to 64 should receive a dose of Tdap as a substitute for the Td vaccine once, then have Td for subsequent boosters.If you previously had the Td vaccine in the last 10 years, ask your doctor if you also need the Tdap vaccine to protect you against whooping cough.Because this vaccine protects against pertussis, the following people should make sure they are up to date with their Tdap immunization:Adults who are in contact with infants under 12 months (Tdap can be given as early as 2 years after you receive the Td vaccine)New mothers who have never received Tdap (during pregnancy, Td is usually preferred over Tdap)Health care workers who are in direct contact with patients (Tdap can normally be given as early as 2 years after you receive the Td vaccine; the Advisory Committee on Immunization Practices suggests that it be given even sooner in health care workers.)Children and adults who have had a severe cut or burn may need Tdap to protect against tetanus infection.RISKS AND SIDE EFFECTSTdap may cause the following mild side effects, which usually last only a few days:Body achesChillsFeverHeadacheNausea, vomiting, diarrheaRashRedness or swelling at the injection siteSoreness at the injection siteCONSIDERATIONSYou should not get the Tdap vaccine if you:Have had a life-threatening allergic reaction to the vaccineHave a severe allergy to any ingredient in the vaccineWent into a coma or had a seizure within 7 days after receiving the DTaP vaccineTalk to your health care provider before getting the Tdap vaccine if you or your child:Have epilepsyor another nervous system problemHad severe swelling or pain after receiving any vaccination containing tetanus, diphtheria, or pertussisHave had Guillain-Barre syndromeHave a severe allergy to latexIf you or your child has a moderate or severe illness, you can delay Tdap vaccination until the illness is gone. People with a mild illness can usually still receive the vaccination.If you cannot take the pertussis vaccine (for example, because of an allergic reaction), you should still receive a vaccine against diphtheria and tetanus (DT for children and Td for adults).CALL YOUR HEALTH CARE PROVIDER IF:You are not sure whether your child should get this vaccineYou or your child develops severe symptoms after a vaccination, such as difficulty breathing, wheezing, hives, weakness, or dizzinessYou have questions or concerns about TdapReferencesCommittee on Infectious Diseases. Recommended childhood and adolescent immunization schedules: United States, 2010. Pediatrics. 2010;125:195-196.Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med. 2010;152(1):36-39.
In the United States, the Centers for Disease Control and Prevention recommend that children receive multiple doses of the whooping cough (pertussis) vaccine as part of the routine childhood vaccination schedule. This includes the DTaP vaccine for infants and young children, and the Tdap vaccine for older children and adolescents. Vaccination coverage rates may vary by region and population.
The first effective polio vaccine was developed in 1952 by Jonas Salk at the University of Pittsburgh. The Salk vaccine, or inactivated poliovirus vaccine (IPV), is based on three wild, virulent reference strains, grown in a type of monkey kidney tissue culture which are then inactivated. An enhanced-potency IPV was licensed in the United States in November 1987, and is currently the vaccine of choice in the United States. In 2002 a combination vaccine (called Pediarix) containing IPV was approved for use in the United States. The vaccine also contains combined diphtheria, tetanus, and acellular pertussis vaccines (DTaP) and a pediatric dose of hepatitis B vaccine.